PharmaPrint Moving Toward In-House Manufacturing Capability
This article was originally published in The Tan Sheet
Executive Summary
PharmaPrint is consolidating its manufacturing operations through an agreement with the contract manufacturer Lone Star Pharmaceuticals, the dietary supplement developer and marketer announced Aug. 16. The deal will serve as a stepping stone toward the construction of an in-house PharmaPrint production and laboratory facility.